MARUX CONTINUOUS BIOMANUFACTURING
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

MARUX CONTINUOUS BIOMANUFACTURING Trademark

Serial Number: 79441470

MARUX CONTINUOUS BIOMANUFACTURING is a trademark filed by Fujifilm Diosynth Biotechnologies UK Limited on November 3, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Fujifilm Diosynth Biotechnologies UK Limited

Belasis Avenue

Entity Type: 24

Trademark Details

Filing Date

November 3, 2025

Registration Date

Not Registered

Goods & Services

Continuous production, including continuous manufacture and purification, of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others; continuous expression, isolation and purification, of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others; continuous connected upstream and downstream production of biological products such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells, to the order and specification of others.

Scientific, industrial and technical research, development and analysis services related to continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; process development related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; industrial design services related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells; provision of facilities for scientific, industrial and technical research development related to the continuous production, including continuous manufacture and purification, of biological products such as such as cells, viruses and biomolecules, including genes and proteins, obtained from recombinant cells.

Filing History

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 2, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 2, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 2, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 2, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 2, 2026 COAR
REFUSAL PROCESSED BY IB
May 21, 2026 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2026 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 1, 2026 RFCS
REFUSAL PROCESSED BY MPU
Apr 30, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 21, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 20, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 18, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 18, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 15, 2026 REPR